Status:
NOT_YET_RECRUITING
Improving Therapeutic Adherence in Cardiovascular Secondary Prevention.
Lead Sponsor:
Universidad Miguel Hernandez de Elche
Conditions:
Cardiovascular Diseases
Chronic Disease
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The goal of this open label randomized controlled trial is to evaluate the efficacy of an intervention through health education based on the Chronic Care Model's implementation to increase therapeutic...
Detailed Description
Cardiovascular diseases are the worldwide's leading cause of mortality. Within the spectrum of these diseases, cerebrovascular disease, coronary heart disease, and peripheral vascular disease are incl...
Eligibility Criteria
Inclusion
- Patients of both sexes, aged over 18 years old, who, after reading the patient information sheet, provide written informed consent.
- Patients in secondary prevention receiving daily single-dose angiotensin converting enzyme inhibitors/Angiotensin II receptor blockers, acetylsalicylic acid, and statins for 6 months or more.
- Diagnosis of any of the following cardiovascular diseases: cerebrovascular disease, ischemic heart disease, or peripheral vascular disease.
- Patients under follow-up at our primary care center.
- Patients identified with therapeutic adherence deficiency, defined as Haynes-Sackett test supplemented with Medication Possession Ratio (MPR) \< 80% for any of the 3 drugs in the previous 6 months.
Exclusion
- Patients who refuse to participate.
- Incomplete completion of informed consent.
- Language barrier.
- Patients diagnosed with psychiatric, psychological, neurological, and/or social problems that hinder intervention or follow-up.
- Life expectancy less than one year.
- Patients whose treatment is managed by a caregiver (professional or family member).
- Patients with Barthel Index \<60.
- Institutionalized patients.
- Patients currently participating in similar research studies.
Key Trial Info
Start Date :
January 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2026
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT06510946
Start Date
January 1 2025
End Date
January 1 2026
Last Update
July 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Babel Health Centre
Alicante, Spain, 03007